Summary

for people ages 40 years and up (full criteria)
at San Francisco, California
study started
estimated completion:

Description

Summary

An extension study for participants who have completed VY-AADC01 or VY-AADC02 Studies

Official Title

An Observational, Long-Term Extension Study for Participants of Prior VY-AADC01 or VY-AADC02 Clinical Studies

Keywords

Parkinson Disease PD Parkinson's Disease Aromatic L-Amino Acid Decarboxylase AADC AAV2 AAV2-AADC VY-AADC

Eligibility

You can join if…

Open to people ages 40 years and up

  1. Participant in Voyager-sponsored clinical study of VY-AADC01 or VY-AADC02 gene therapy
  2. Ability to comprehend and signed the informed consent, or for participants who are not capable of providing consent, have a healthcare proxy, or person with power of attorney, who is able and willing to give consent on behalf of the participant
  3. Capable of complying with the protocol

You CAN'T join if...

Location

  • University of California, San Francisco
    San Francisco California 94143 United States

Details

Status
accepting new patients by invitation only
Start Date
Completion Date
(estimated)
Sponsor
Voyager Therapeutics
ID
NCT03733496
Study Type
Observational
Last Updated